Literature DB >> 25911292

"Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Mak Adam Daulatzai1.   

Abstract

Brain damage begins years before substantial neurodegeneration and Alzheimer's dementia. Crucial fundamental activities of life are breathing, eating, drinking, and sleeping. When these pivotal functions are maligned over a prolonged period, they impart escalating dyshomeostasis. The latter may lead to disastrous consequences including cognitive dysfunction and Alzheimer's disease (AD). The current theme here is that multiple pathophysiological derangements are promoted over a prolonged period by the very fundamental activities of life-when "rendered unhealthy." They may converge on several regulating/modulating factors (e.g., mitochondrial energy production, oxidative stress, innate immunity, and vascular function) and promote insidious neuropathology that culminates in cognitive decline in the aged. This is of course associated with the accumulation of amyloid beta and phosphorylated tau in the brain. Epidemiological, biomarker, and neuroimaging studies have provided significant copious evidence on the presence of indolent prodromal AD neuropathology many years prior to symptomatic onset. Progressive oxidative damage to specific gene promoters may result in gene silencing. A mechanistic link may possibly exist between epigenomic state, DNA damage, and chronically unhealthy/dysfunctional body systems. This paper, therefore, addresses and delineates the deleterious pathophysiological impact triggered by dysfunctional breathing, harmful diet, excess of alcohol consumption, and sleep deprivation; indeed, their impact may alter epigenetic state. It is mandatory, therefore, to abrogate cognitive decline and attenuate AD pathology through adoption of a healthy lifestyle, in conjunction with combination therapy with known moderators of cognitive decline. This strategy may thwart multiple concurrent and synergistic pathologies, including epigenetic dysfunction. A multi-factorial therapeutic intervention is required to overcome wide ranging neuropathology and multi-faceted disease process. Such an approach may attenuate neuropathology and ameliorate memory dysfunction.

Entities:  

Mesh:

Year:  2015        PMID: 25911292     DOI: 10.1007/s12640-015-9528-x

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  551 in total

Review 1.  Homocysteine metabolism.

Authors:  J Selhub
Journal:  Annu Rev Nutr       Date:  1999       Impact factor: 11.848

Review 2.  Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

Authors:  Paul S Aisen; Ronald C Petersen; Michael C Donohue; Anthony Gamst; Rema Raman; Ronald G Thomas; Sarah Walter; John Q Trojanowski; Leslie M Shaw; Laurel A Beckett; Clifford R Jack; William Jagust; Arthur W Toga; Andrew J Saykin; John C Morris; Robert C Green; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

Review 3.  Obstructive sleep apnoea, insulin resistance and adipocytokines.

Authors:  David C L Lam; Karen S L Lam; Mary S M Ip
Journal:  Clin Endocrinol (Oxf)       Date:  2014-10-29       Impact factor: 3.478

4.  Coronary flow velocity reserve is impaired in hypertensive patients with hyperhomocysteinemia.

Authors:  J Liu; Y Xu; H Zhang; X Gao; H Fan; G Wang
Journal:  J Hum Hypertens       Date:  2014-03-27       Impact factor: 3.012

5.  Greater loss of 5-HT(2A) receptors in midlife than in late life.

Authors:  Yvette I Sheline; Mark A Mintun; Stephen M Moerlein; Abraham Z Snyder
Journal:  Am J Psychiatry       Date:  2002-03       Impact factor: 18.112

6.  Treadmill Running Reverses Cognitive Declines due to Alzheimer Disease.

Authors:  Jinkyung Cho; Min-Kyoo Shin; Donghyun Kim; Inhwan Lee; Shinuk Kim; Hyunsik Kang
Journal:  Med Sci Sports Exerc       Date:  2015-09       Impact factor: 5.411

7.  Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease.

Authors:  T Arendt; V Bigl; A Arendt; A Tennstedt
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

8.  Dose-dependent effects of ethanol and E. coli on gut permeability and cytokine production.

Authors:  Parth B Amin; Lawrence N Diebel; David M Liberati
Journal:  J Surg Res       Date:  2008-12-10       Impact factor: 2.192

9.  Platelet-activating factor receptor-deficient mice are protected from experimental sleep apnea-induced learning deficits.

Authors:  Barry W Row; Leila Kheirandish; Richard C Li; Shang Z Guo; Kenneth R Brittian; Mattie Hardy; Nicolas G Bazan; David Gozal
Journal:  J Neurochem       Date:  2004-04       Impact factor: 5.372

Review 10.  Epigenetic control of gene expression in the alcoholic brain.

Authors:  Igor Ponomarev
Journal:  Alcohol Res       Date:  2013
View more
  3 in total

Review 1.  The relationship between different dimensions of alcohol use and the burden of disease-an update.

Authors:  Jürgen Rehm; Gerhard E Gmel; Gerrit Gmel; Omer S M Hasan; Sameer Imtiaz; Svetlana Popova; Charlotte Probst; Michael Roerecke; Robin Room; Andriy V Samokhvalov; Kevin D Shield; Paul A Shuper
Journal:  Addiction       Date:  2017-02-20       Impact factor: 6.526

2.  Neuroprotective effects of some epigenetic modifying drugs' on Chlamydia pneumoniae-induced neuroinflammation: A novel model.

Authors:  Elif Kaya-Tilki; Miriş Dikmen
Journal:  PLoS One       Date:  2021-11-30       Impact factor: 3.240

Review 3.  Repurposing Licensed Drugs for Use Against Alzheimer's Disease.

Authors:  Leslie C Norins
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.